Trial · NCT02986919
Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors
NCT02986919, Phase 2, Withdrawn, University of Texas Southwestern Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors. Trials, record NCT02986919. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02986919
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors
- NCT number
- NCT02986919
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- University of Texas Southwestern Medical Center
- Conditions
- Peripheral Nerve Tumors
- Interventions
- CPI-0610
- First posted
- 2016-12-08
- Last updated
- 2018-09-11
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response rate of CPI-0610 | 21 day cycles for 84 days | Establish the response rate of CPI-0610 in MPNST patients |
| Primary | Duration of CPI-0610 | 21 day cycles for 84 days | Establish the response duration of CPI-0610 in MPNST patients |
| Primary | Adverse events associated with CPI-0610 | 21 day cycles for 84 days | Describe the adverse events associated with CPI-0610 at the RP2D |
| Secondary | Correlate tumor exposure to CPI-0610 with tumor BIM1 expression | 21 day cycles for 84 days | Correlate tumor exposure to CPI-0610 with tumor BIM1 expression |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02986919
GET https://conductscience.org/api/trials/v1/NCT02986919/registered